Feds say medical cannabis no excuse for positive THC test (Newsletter: October 12, 2023)
Marijuana protections in climate workforce bill; Ukraine medical cannabis vote; Study: Marijuana consumers get better
CT cannabis sales pass $25 million in September; recreational use hits $14 million
Sales of cannabis in Connecticut passed $25 million in September for the first time, the
Court to allow Cannabis Commission to create new licensure rules
The counsel for one awardee, Verano, argued that the commission does not have the authority
Unrivaled Brands to Become Blüm Holdings
Nevada-based cannabis company Unrivaled Brands Inc. (OTCQB: UNRV), which has operations across California, plans to
Atai Leans Into IntelGenx
Atai Life Sciences AG (Nasdaq: ATAI) clearly believes in the medical technology from IntelGenx Technologies
Alaska Will Regulate Hemp-Derived Cannabinoid Products Through Marijuana Control Board
“If you want intoxicating cannabinoids, you should visit your local friendly marijuana retailer.” By James
Ukrainian Lawmakers Approve Medical Marijuana Legalization Bill In Committee, Putting It One More Vote From Zelensky’s Desk
A bill to legalize medical marijuana in Ukraine has cleared a key legislative hurdle, advancing
Feds Clarify That Doctor-Recommended Medical Marijuana Is No Excuse For A Positive THC Test Under New Workplace Guidelines
A top health agency has formally revised federal workplace drug testing guidelines to clarify that
Alabama Medical Cannabis Regulators Seek To Dismiss Verano’s Licensing Lawsuit
“Is there any circumstance that you can think of that would allow the commission to
New Mexico Considering Marijuana Business License Fee Hike
The proposal also includes new disclosure requirements for business applicants. Some cannabis microbusinesses in New